Florida vaccine demand dips amid Johnson & Johnson pause
On Friday, a U.S. health panel said it's time to resume use of the Johnson & Johnson COVID-19 vaccine, despite a very rare risk of blood clots. The government will rapidly weigh th…
On Friday, a U.S. health panel said it's time to resume use of the Johnson & Johnson COVID-19 vaccine, despite a very rare risk of blood clots. The government will rapidly weigh th…